Search by Drug Name or NDC
NDC 62332-0599-25 Ketorolac Tromethamine 15 mg/mL Details
Ketorolac Tromethamine 15 mg/mL
Ketorolac Tromethamine is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is KETOROLAC TROMETHAMINE.
Product Information
| NDC | 62332-0599 |
|---|---|
| Product ID | 62332-599_84fec05c-9464-4148-a63c-05bfd6b88088 |
| Associated GPIs | |
| GCN Sequence Number | 039499 |
| GCN Sequence Number Description | ketorolac tromethamine VIAL 15 MG/ML INJECTION |
| HIC3 | S2B |
| HIC3 Description | NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS |
| GCN | 35238 |
| HICL Sequence Number | 005175 |
| HICL Sequence Number Description | KETOROLAC TROMETHAMINE |
| Brand/Generic | Generic |
| Proprietary Name | Ketorolac Tromethamine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ketorolac Tromethamine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 15 |
| Active Ingredient Units | mg/mL |
| Substance Name | KETOROLAC TROMETHAMINE |
| Labeler Name | Alembic Pharmaceuticals Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214456 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62332-0599-25 (62332059925)
| NDC Package Code | 62332-599-25 |
|---|---|
| Billing NDC | 62332059925 |
| Package | 25 VIAL in 1 CARTON (62332-599-25) / 1 mL in 1 VIAL (62332-599-01) |
| Marketing Start Date | 2022-11-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |